In light of the rapidly changing coronavirus (COVID-19) situation, Troutman Sanders and Pepper Hamilton have postponed the effective date of their previously announced merger until July 1, 2020. The new firm – Troutman Pepper – will feature 1,100+ attorneys across 23 U.S. offices. Read more.
Pepper Hamilton offers clients one of the largest and strongest teams in the country devoted to representing pharmaceutical and medical device companies in complex litigation and investigations matters.
Pepper's 90+ professionals represent some of the world’s leading pharmaceutical and medical device companies, including GlaxoSmithKline, Eli Lilly, Merck, Medtronic, and Bristol-Myers Squibb. Our relationships with many of these clients extend for decades. Clients and competitors rank our team among the top products liability firms in the country in such publications as Chambers USA, and many of our lawyers are recognized as masters in their field by Chambers, Best Lawyers, Super Lawyers and other industry watchers. In addition to successfully defending clients in litigation and government investigations, we are skilled at providing counseling, particularly on lowering litigation risk.
What We Do
We represent pharmaceutical and medical device manufacturers facing such challenges as: civil and criminal investigations by the DOJ and other federal agencies; actions by state attorneys general under consumer protection and Medicaid fraud statutes; tens of thousands of individual personal injury claims, whether presented individually, in MDLs, or in coordinated state court proceedings; and class actions by consumers and third-party payors. We also conduct risk assessments and counsel clients on risk mitigation. A hallmark of our practice is our track record as national counsel assisting clients through the “perfect storm” of simultaneous lawsuits, grand jury investigations and regulatory actions.